Evaluation of a Diabetic Ketoacidosis Order Set in Adults With Type 1 and Type 2 Diabetes at a Tertiary Academic Medical Centre: A Retrospective Chart Audit

Can J Diabetes. 2019 Jul;43(5):304-308.e3. doi: 10.1016/j.jcjd.2018.11.004. Epub 2018 Nov 17.

Abstract

Objective: To assess safety and efficacy compared to a historical cohort. Clinical practice guidelines recommend that patients with diabetic ketoacidosis (DKA) be treated with a standardized protocol. We created a multifaceted order set to promote best-practice management of DKA.

Methods: We performed a retrospective cohort study of admissions to internal medicine for DKA in adults during a 4.5-year period; 2.25 years before and after order-set initiation. Groups were compared using independent samples t tests and Pearson chi-square or Fisher exact test (categorical data). The Mann-Whitney U test was used for continuous data not normally distributed.

Results: The order-set cohort consisted of 47 admissions, 72.3% with type 1 and 27.7% with type 2 diabetes. The historical cohort consisted of 59 admissions, 69.5% with type 1 and 30.5% with type 2 diabetes. There were no significant differences in initial laboratory values between patients with type 1 and type 2 diabetes in both cohorts. The median length of hospital stay approached significance in the order-set cohort: 3.53 days (2.5 to 5.1); in the historical cohort, the median length of stay was 4.6 days (2.44 to 8.99) (p=0.102).

Conclusion: A standardized DKA order set was as effective and safe in type 1 and type 2 diabetes as individual physician management in an academic care setting. Further study is needed to assess its value in community hospital settings with less expertise and fewer diabetes specialty services.

Keywords: acidocétose diabétique; diabetic ketoacidosis; ensemble d'ordonnances; in-hospital; management; order set; prise en charge; protocol; protocole; à l'hôpital.

MeSH terms

  • Academic Medical Centers / statistics & numerical data*
  • Adult
  • Biomarkers / analysis*
  • Diabetes Mellitus, Type 1 / complications*
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetic Ketoacidosis / etiology
  • Diabetic Ketoacidosis / therapy*
  • Disease Management
  • Female
  • Fluid Therapy
  • Follow-Up Studies
  • Hospitalization / statistics & numerical data
  • Humans
  • Male
  • Medical Audit / statistics & numerical data*
  • Middle Aged
  • Patient Care / methods
  • Patient Care / standards*
  • Prognosis
  • Retrospective Studies
  • Tertiary Care Centers

Substances

  • Biomarkers